Genexine Inc Cash Flow Quality Index

Latest as of September 2025: -0.14x

Genexine Inc cash flow quality index. Genexine Inc (095700) has a Cash Flow Quality Index of -0.14x as of September 2025. Operating cash flow of ₩-2.97 Billion is below net income of ₩21.05 Billion, suggesting accrual-heavy earnings not yet converted to cash. See 095700 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.14x
Operating CF / Net Income

Operating Cash Flow

₩-2.97 Billion
KRW

Net Income

₩21.05 Billion
KRW

Data as of

Sep 2025
Most recent filing

Cash Flow Quality Index of Genexine Inc (2020–2020)

Cash flow quality index of Genexine Inc from 2020 to 2020. Historical Cash Flow Quality Index for Genexine Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 095700 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Genexine Inc Cash Flow Quality Index by Year (2020–2020)

Genexine Inc cash flow quality index by year from 2020 to 2020. Year-by-year earnings quality comparison for Genexine Inc. For the full cash flow conversion analysis, see Genexine Inc (095700) cash conversion ratio.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2020 -0.82x ₩-22.69 Billion ₩27.57 Billion —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.